502
Views
6
CrossRef citations to date
0
Altmetric
Commentary

Eccrine angiomatous hamartoma with sudden enlargement and pain in an adolescent girl after menarche

, , , , &
Pages 266-268 | Published online: 01 Oct 2011

Abstract

Eccrine angiomatous hamartoma (EAH) is a rare, benign cutaneous lesion characterized histologically by a proliferation of eccrine glands and vascular structures—generally capillaries—in the middle and deep dermis. Sudden enlargement of EAH lesions with or without pain has been noted during puberty and pregnancy and has been attributed to hormonal stimulation. We herein describe a case of EAH that became symptomatic in an adolescent girl. A 13-year-old girl presented with pain associated with a sudden enlargement of a previously asymptomatic swelling on her right second toe. She had an 8-year history of an asymptomatic swelling on her right second toe, and the symptoms appeared approximately 1 year after menarche. Physical examination revealed swelling of the plantar surface of her right second toe. The overlying surface was erythematous with a small amount of fine scales. The biopsied tissue showed a nodular proliferation of eccrine glands intimately admixed with numerous small vessels in the deep dermis and subcutaneous fat tissue. Mucin deposition was present in the stroma surrounding the proliferating eccrine coils and ducts and in the upper dermis. A diagnosis of EAH was made. We suggest that hormonal changes during puberty may have played a role in the rapid growth and pain in the present case.

Eccrine angiomatous hamartoma (EAH) is a rare, benign cutaneous lesion characterized histologically by a proliferation of eccrine glands and vascular structures in the dermis.Citation1Citation4 It usually arises at birth or during early infancy and childhood as a nodule or a plaque predominantly involving the distal extremities. Although some EAH cases are asymptomatic, pain and hyperhidrosis are common. Sudden enlargement of EAH lesions with or without pain has been noted during pubertyCitation1,Citation3,Citation5 and pregnancy.Citation6 Here, we describe a case of EAH on the right second toe of an adolescent girl. Although the EAH lesion has been asymptomatic for 7 years since its appearance when she was 5 years old, it grew rapidly with pain approximately 1 year after menarche.

A 13-year-old Japanese girl had an 8-year history of a swelling on her right second toe. The swelling had been growing slowly until 5 months prior to presentation, when it began to grow rapidly and was associated with tenderness. She also began to feel pain when she stood for a long time. Sixteen days before presenting to our clinic, she had attended her junior high school athletic meet and the swelling became painful. Physical examination revealed swelling of the plantar surface of her right second toe (). The overlying surface was erythematous with a small amount of fine scales ( and C). Although the patient reported an episode of hyperhidrosis of the affected toe, hyperhidrosis was not evident on examination. A skin biopsy showed acanthosis with hypertrophy of the granular layer, mild elongation of rete ridges and a mild, perivascular inflammatory infiltration in the superficial dermis (). In the deep dermis and subcutaneous fat tissue, there was a proliferation of normally structured eccrine coils and ducts ( and F). Extravasation of erythrocytes was also noted around the eccrine glands (). There was an abundant deposition of mucinous material in the stroma surrounding the proliferating eccrine coils and ducts ( and F). Proliferation of small capillary-sized vessels was observed in some areas of the stroma in subcutaneous fat tissues (). The mucinous material in the stroma was confirmed as mucin by Alcian blue stain (data not shown). Mucin deposition was also present in the upper dermis (data not shown). Immunohistochemical examination showed that the eccrine coils and ducts were stained positively for CEA, S-100 and EMA (data not shown). A diagnosis of EAH was made. Several painful skin tumors and malformations () were ruled out based on histological findings. We plan to excise the lesion if the pain becomes severe.

The natural course of EAH is enlargement commensurate with growth of the patient.Citation7 Spontaneous regression has been observed in one case.Citation8 EAH is a benign lesion and, as a rule, aggressive treatment is unnecessary if asymptomatic.Citation1,Citation2,Citation9 Associated pain and cosmesis are the most common reasons for treatment of EAH.Citation1,Citation2,Citation4 Localized, small lesions can be cured by simple local excision.Citation1,Citation2 However, some cases with severe pain required amputationCitation6 or high doses of analgesics.Citation10

Several mechanisms of pain and/or tenderness in EAH have been postulated. Electron microscopy revealed the presence of tubular structures infiltrating the neural sheaths of small dermal nerves,Citation11 which were hypothesized to be a potential source of the pain. Sulica et al. suggested that the pain and tenderness may have resulted from swelling or compression of nerves by hamartomatous tissue, rather than actual proliferation of neural elements in the growth. In some cases, EAH lesions grew rapidly during puberty and pregnancy;Citation1,Citation3Citation6 thus, some authors suggested that the rapid growth and/or pain were caused by hormonal stimulation,Citation6,Citation7 although specific hormones have not been identified nor suggested. In one case, hormones related with menstrual cycle such as estrogen, progesterone, luteinizing hormone and follicle stimulating hormone are possible candidates for the responsible hormone(s). In addition, Gabrielsen et al. suggested that pain may occur due to fluid retention associated with pregnancy. In our case, although the cutaneous lesion had been asymptomatic for about seven years, pain and rapid growth occurred about one year after menarche, suggesting that hormonal change may have influenced the rapid growth and pain.

It has been postulated that the focal hyperhidrosis of EAH is an expression of its eccrine components.Citation12,Citation13 Botulinum toxin has been successfully used to treat the hyperhidrosis of EAH.Citation14

To the best of our knowledge, fewer than 10 cases of EAH with mucin deposition have been reported. The main difference between the present case and previously reported cases is that there was mucin deposition not only in the stroma surrounding the eccrine glands and vascular structures but also in the superficial dermis in the present case.

Figures and Tables

Figure 1 Clinical appearance of the skin lesion. (A–C) Swelling of the plantar surface was apparent on the right second toe. The overlying surface was erythematous with a small amount of fine scales. Histologically, the epidermis showed acanthosis with hypertrophy of the granular layer and mild elongation of rete ridges. (D) A mild, perivascular inflammatory infiltration in the upper dermis was seen (hematoxylin and eosin, original magnification x40). (E) A nodular proliferation of normally structured eccrine coils and ducts in the deep dermis and subcutaneous fat tissue. Some of the ducts show mild dilation. Extravasation of erythrocytes was also noted around the proliferation of eccrine glands (hematoxylin and eosin, original magnification x200). (F) Proliferation of small capillary-sized vessels in the stroma surrounding the eccrine glands in the subcutaneous fat tissues (hematoxylin and eosin, original magnification x200).

Figure 1 Clinical appearance of the skin lesion. (A–C) Swelling of the plantar surface was apparent on the right second toe. The overlying surface was erythematous with a small amount of fine scales. Histologically, the epidermis showed acanthosis with hypertrophy of the granular layer and mild elongation of rete ridges. (D) A mild, perivascular inflammatory infiltration in the upper dermis was seen (hematoxylin and eosin, original magnification x40). (E) A nodular proliferation of normally structured eccrine coils and ducts in the deep dermis and subcutaneous fat tissue. Some of the ducts show mild dilation. Extravasation of erythrocytes was also noted around the proliferation of eccrine glands (hematoxylin and eosin, original magnification x200). (F) Proliferation of small capillary-sized vessels in the stroma surrounding the eccrine glands in the subcutaneous fat tissues (hematoxylin and eosin, original magnification x200).

Table 1 Painful skin tumors/malformations

References

  • Sulica RL, Kao GF, Sulica VI, Penneys NS. Eccrine angiomatous hamartoma (nevus): immunohistochemical findings and review of the literature. J Cutan Pathol 1994; 21:71 - 75
  • Nakatsui TC, Schloss E, Krol A, Lin AN. Eccrine angiomatous hamartoma: report of a case and literature review. J Am Acad Dermatol 1999; 41:109 - 111
  • Pelle MT, Pride HB, Tyler WB. Eccrine angiomatous hamartoma. J Am Acad Dermatol 2002; 47:429 - 435
  • Martinelli PT, Tschen JA. Eccrine angiomatous hamartoma: a case report and review of the literature. Cutis 2003; 71:449 - 455
  • Morrell DS, Ghali FE, Stahr BJ, McCauliffe DP. Eccrine angiomatous hamartoma: a report of symmetric and painful lesions of the wrists. Pediatr Dermatol 2001; 18:117 - 119
  • Gabrielsen TO, Elgjo K, Sommerschild H. Eccrine angiomatous hamartoma of the finger leading to amputation. Clin Exp Dermatol 1991; 16:44 - 45
  • Larralde M, Bazzolo E, Boggio P, Abad ME, Santos Muñoz A. Eccrine angiomatous hamartoma: report of five congenital cases. Pediatr Dermatol 2009; 26:316 - 319
  • Tay YK, Sim CS. Eccrine angiomatous hamartoma associated with spontaneous regression. Pediatr Dermatol 2006; 23:516 - 517
  • López V, Pinazo I, Santonja N, Jordá E. Eccrine angiomatous hamartoma in a child. Pediatr Dermatol 2010; 27:548 - 549
  • Wolf R, Krakowski A, Dorfman B, Baratz M. Eccrine angiomatous hamartoma. A painful step. Arch Dermatol 1989; 125:1489 - 1490
  • Challa VR, Jona J. Eccrine angiomatous hamartoma: a rare skin lesion with diverse histological features. Dermatologica 1997; 155:206 - 209
  • Sanmartin O, Botella R, Alegre V, Martinez A, Aliaga A. Congenital eccrine angiomatous hamartoma. Am J Dermatopathol 1992; 14:161 - 164
  • Calderone DC, Glass LF, Seleznick M, Fenske NA. Eccrine angiomatous hamartoma. J Dermatol Surg Oncol 1994; 20:837 - 838
  • Barco D, Baselga E, Alegre M, Curell R, Alomar A. Successful treatment of eccrine angiomatous hamartoma with botulinum toxin. Arch Dermatol 2009; 145:241 - 243